[{"address1": "259 Liberty Avenue", "city": "Staten Island", "state": "NY", "zip": "10305", "country": "United States", "phone": "917 533 1469", "website": "https://www.acurxpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. DeLuccia", "age": 78, "title": "Co-Founder & Executive Chairman", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 818930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David P. Luci CPA, Esq., J.D.", "age": 57, "title": "Co-Founder, President, CEO, Corporate Secretary & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 786883, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Shawah CPA", "age": 57, "title": "Co-Founder & CFO", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 533653, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.74, "open": 4.68, "dayLow": 4.5, "dayHigh": 4.9, "regularMarketPreviousClose": 4.74, "regularMarketOpen": 4.68, "regularMarketDayLow": 4.5, "regularMarketDayHigh": 4.9, "payoutRatio": 0.0, "forwardPE": -2.9612906, "volume": 66851, "regularMarketVolume": 66851, "averageVolume": 585393, "averageVolume10days": 79550, "averageDailyVolume10Day": 79550, "bid": 4.78, "ask": 5.28, "bidSize": 1, "askSize": 1, "marketCap": 10029348, "fiftyTwoWeekLow": 3.8, "fiftyTwoWeekHigh": 35.4, "allTimeHigh": 176.4, "allTimeLow": 3.8, "fiftyDayAverage": 5.2689, "twoHundredDayAverage": 7.93624, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3665014, "profitMargins": 0.0, "floatShares": 1712250, "sharesOutstanding": 2081323, "sharesShort": 34802, "sharesShortPriorMonth": 63713, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0167, "heldPercentInsiders": 0.061669998, "heldPercentInstitutions": 0.091709994, "shortRatio": 0.02, "shortPercentOfFloat": 0.0168, "impliedSharesOutstanding": 2185043, "bookValue": 2.02, "priceToBook": 2.2722774, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -9170053, "trailingEps": -10.57, "forwardEps": -1.55, "lastSplitFactor": "1:20", "lastSplitDate": 1754352000, "52WeekChange": -0.86058825, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 4.59, "targetHighPrice": 165.8, "targetLowPrice": 20.0, "targetMeanPrice": 61.7, "targetMedianPrice": 30.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 5906802, "totalCashPerShare": 2.833, "totalDebt": 0, "quickRatio": 2.409, "currentRatio": 2.474, "returnOnAssets": -0.95689005, "returnOnEquity": -2.91065, "freeCashflow": -5405750, "operatingCashflow": -7853440, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ACXP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763164449, "regularMarketTime": 1763154001, "exchange": "NCM", "messageBoardId": "finmb_558025934", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.16455, "shortName": "Acurx Pharmaceuticals, Inc.", "marketState": "CLOSED", "regularMarketPrice": 4.59, "postMarketChangePercent": 0.0, "postMarketPrice": 4.59, "postMarketChange": 0.0, "regularMarketChange": -0.15, "regularMarketDayRange": "4.5 - 4.9", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 585393, "fiftyTwoWeekLowChange": 0.7900002, "fiftyTwoWeekLowChangePercent": 0.20789479, "fiftyTwoWeekRange": "3.8 - 35.4", "fiftyTwoWeekHighChange": -30.810001, "fiftyTwoWeekHighChangePercent": -0.870339, "fiftyTwoWeekChangePercent": -86.05882, "earningsTimestamp": 1762954200, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "earningsCallTimestampStart": 1762952400, "earningsCallTimestampEnd": 1762952400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -10.57, "epsForward": -1.55, "epsCurrentYear": -5.7, "priceEpsCurrentYear": -0.8052632, "fiftyDayAverageChange": -0.67889977, "fiftyDayAverageChangePercent": -0.12885039, "twoHundredDayAverageChange": -3.34624, "twoHundredDayAverageChangePercent": -0.42164046, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-25", "prevName": "Acurx Pharmaceuticals, LLC", "nameChangeDate": "2025-11-14", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624627800000, "longName": "Acurx Pharmaceuticals, Inc.", "displayName": "Acurx Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]